Clinical Trials
6
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (66.7%)Phase 1
2 (33.3%)Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults
Phase 2
Recruiting
- Conditions
- Immune Deficiency
- Interventions
- Other: Normal Saline Placebo
- First Posted Date
- 2022-06-16
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Qu Biologics Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT05421325
- Locations
- 🇨🇦
Qu Biologics Trial Site, Burnaby, British Columbia, Canada
QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease
Phase 2
Terminated
- Conditions
- Crohn Disease
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2021-05-18
- Lead Sponsor
- Qu Biologics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03472690
- Locations
- 🇨🇦
Fraser Clinical Trials, New Westminster, British Columbia, Canada
🇨🇦G.I. Research Institute, Vancouver, British Columbia, Canada
🇨🇦McMaster University Medical Centre, Hamilton, Ontario, Canada
Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers
Phase 1
Withdrawn
- Conditions
- Healthy
- First Posted Date
- 2016-09-13
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- Qu Biologics Inc.
- Registration Number
- NCT02897999
Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis
Phase 2
Completed
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2015-04-24
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- Qu Biologics Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT02426372
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦GI Research Institute, Vancouver, British Columbia, Canada
🇨🇦McMaster University, Hamilton, Ontario, Canada
Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2014-10-06
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- Qu Biologics Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT02256852
- Locations
- 🇨🇦
BC Cancer Research Centre, Vancouver, Canada
- Prev
- 1
- 2
- Next
News
No news found